跳至主要内容
临床试验/CTRI/2024/05/067056
CTRI/2024/05/067056尚未招募4 期

Influenza Vaccine to reduce cardiovascular events in patients with recent myocardial infarction: a multicentric randomized, double-blind palcebo-controlled trial. - NI

Indian Council of Medical Research, India0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients > 45 year old with physician diagnosed MI (ST elevation and non ST elevation) in the previous 12 weeks consenting to participate will be randomized to intervention or control arm

排除标准

  • 1) Anaphylactic reaction to a previous dose of influenza vaccine,
  • 2) IgE-mediated hypersensitivity to egg protein manifested as hives, swelling of the mouth and throat, difficulty in breathing, hypotension, or shock;
  • 3) Guillain-Barré syndrome within eight weeks of a previous influenza vaccine;
  • 4) Anaphylactic reaction to neomycin
  • 5) Influenza vaccine in the previous one year;
  • 6) Plan to be vaccinated with flu vaccine in coming year

研究者

发起方
Indian Council of Medical Research, India

相似试验

Impact of Influenza Vaccine in reducing adverse... | 临床试验